Un nouvel ouvrage examine le potentiel des champignons hallucinogènes pour traiter le trouble obsessionnel-compulsif, souvent qualifié de « trouble du doute ».
L'extrait décrit une scène à New York où Adam Strauss hésite entre deux lecteurs MP3 tout en tenant le fil de ses écouteurs. Il s'appuie sur l'idée que le TOC est une forme d'incertitude et s'interroge sur la capacité de la psilocybine à réduire ce doute.
Rapporté par l'IA Image générée par IA
Researchers at Uppsala University have shown that a short treatment program involving Tetris can reduce intrusive memories in healthcare staff after trauma.
President Donald Trump signed an executive order on Saturday directing federal agencies to accelerate access to psychedelic drugs like psilocybin and ibogaine for treating mental health conditions, including depression, anxiety, and PTSD. The order allocates $50 million in funding and instructs the FDA to prioritize reviews. Trump was joined by Health and Human Services Secretary Robert F. Kennedy Jr., Dr. Mehmet Oz, former Navy SEAL Marcus Luttrell, and podcast host Joe Rogan.
Rapporté par l'IA
An 83-year-old woman with severe Alzheimer’s disease began speaking in full sentences and regained bladder control after taking a large dose of psilocybin. The changes occurred following a single session with the psychedelic compound derived from magic mushrooms. Researchers describe the case as dramatic but stress it is only one anecdotal report.
Researchers have identified a specific group of neurons in the amygdala that plays a central role in anxiety and social withdrawal. By restoring normal activity in this circuit, they reversed anxiety-related behaviors in mice. The findings point to a potential new target for treating emotional disorders.
Rapporté par l'IA
Researchers at MIT have discovered that chaotic laser light can self-organize into a highly focused pencil beam, enabling 3D imaging of the blood-brain barrier 25 times faster than current methods. The technique allows real-time observation of drugs entering brain cells without fluorescent tags. This breakthrough could speed up development of treatments for neurological diseases like Alzheimer's and ALS.